Defining conversion therapy for esophageal squamous cell carcinoma

被引：14

作者：

Matsuda, Satoru ^{[1
]}

Tsushima, Takahiro ^{[2
]}

Kato, Ken ^{[3
]}

Hsu, Chih-Hung ^{[4
]}

Lee, Jang Ming ^{[5
]}

Wong, Ian Yu-Hong ^{[6
]}

Wang, Hu-Lin Christina ^{[7
]}

Kang, Chang Hyun ^{[8
]}

Guo, Xufeng ^{[9
]}

Yamamoto, Shun ^{[3
]}

Tsuji, Takayuki ^{[1
]}

Kawakubo, Hirofumi ^{[1
]}

Takeuchi, Hiroya ^{[10
]}

Law, Simon ^{[6
]}

Kitagawa, Yuko ^{[1
]}

机构：

[1] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan

[2] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[3] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan

[4] Natl Taiwan Univ Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan

[5] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan

[6] Univ Hong Kong, Sch Clin Med, Dept Surg, Hong Kong, Peoples R China

[7] Far Eastern Mem Hosp, Div Traumatol, Taipei, Taiwan

[8] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea

[9] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China

[10] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka, Japan

来源：

ANNALS OF GASTROENTEROLOGICAL SURGERY | 2023年 / 7卷 / 01期

关键词：

conversion surgery; conversion therapy; esophageal squamous cell carcinoma; CHEMOTHERAPY; CANCER;

D O I：

10.1002/ags3.12623

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.

引用

页码：7 / 9

页数：3

共 50 条

[31] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
Shiraishi, Kazuhiro
Okada, Mao
Yamamoto, Shun
Matsubara, Yuki
Masuishi, Toshiki
Shimozaki, Keitaro
Yamamoto, Yoshiyuki
Hirose, Suguru
Sugiyama, Keiji
Furuta, Mitsuhiro
Machida, Nozomu
Takahashi, Naoki
Yoshii, Takako
Kito, Yosuke
Tsuzuki, Takao
Boku, Shogen
Tsuchihashi, Kenji
Sugaya, Akinori
Takayama, Toshizo
Komori, Azusa
Mitani, Seiichiro
Matsumoto, Toshihiko
Nishimura, Takashi
Hirata, Kenro
SCIENTIFIC REPORTS, 2025, 15 (01):
[32] Autophagy: A Potential Mechanism for Resistance of Esophageal Squamous Cell Carcinoma to Therapy
Liu, Dong-Lei
Zhang, Ji-Guang
Wang, Jian-Jun
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (11) : 775 - 776
[33] Trimodality therapy for esophageal squamous cell carcinoma: Is it really a medical palindrome?
Ahmad, Usman
Murthy, Sudish C.
Raja, Siva
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (02): : 741 - 742
[34] Epidemiology of Esophageal Squamous Cell Carcinoma
Abnet, Christian C.
Arnold, Melina
Wei, Wen-Qiang
GASTROENTEROLOGY, 2018, 154 (02) : 360 - 373
[35] NOTCH and Esophageal Squamous Cell Carcinoma
Li, Yong
Li, Yahui
Chen, Xiaoxin
NOTCH SIGNALING IN EMBRYOLOGY AND CANCER: NOTCH SIGNALING IN CANCER, 2020, 1287 : 59 - 68
[36] Immunotherapy for Esophageal Squamous Cell Carcinoma
Takashi Kojima
Toshihiko Doi
Current Oncology Reports, 2017, 19
[37] ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
SERRA, LB
BRITISH JOURNAL OF SURGERY, 1981, 68 (04) : 292 - 292
[38] MicroRNAs and Esophageal Squamous Cell Carcinoma
Matsushima, Kayoko
Isomoto, Hajime
Kohno, Shigeru
Nakao, Kazuhiko
DIGESTION, 2010, 82 (03) : 138 - 144
[39] Chemoprevention of esophageal squamous cell carcinoma
Stoner, Gary D.
Wang, Li-Shu
Chen, Tong
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) : 337 - 349
[40] Immunotherapy for Esophageal Squamous Cell Carcinoma
Kojima, Takashi
Doi, Toshihiko
CURRENT ONCOLOGY REPORTS, 2017, 19 (05)

← 1 2 3 4 5 →